Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paolo Fiorina, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Paolo Fiorina and Reza Abdi.
Paolo Fiorina
Connection Strength
7.807
Reza Abdi
  1. Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1. J Immunol. 2011 Jan 01; 186(1):121-31.
    View in: PubMed
    Score: 0.454
  2. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol. 2009 Jul 15; 183(2):993-1004.
    View in: PubMed
    Score: 0.411
  3. Phenotypic and functional differences between wild-type and CCR2-/- dendritic cells: implications for islet transplantation. Transplantation. 2008 Apr 15; 85(7):1030-8.
    View in: PubMed
    Score: 0.378
  4. Characterization of donor dendritic cells and enhancement of dendritic cell efflux with CC-chemokine ligand 21: a novel strategy to prolong islet allograft survival. Diabetes. 2007 Apr; 56(4):912-20.
    View in: PubMed
    Score: 0.348
  5. Role of CXC chemokine receptor 3 pathway in renal ischemic injury. J Am Soc Nephrol. 2006 Mar; 17(3):716-23.
    View in: PubMed
    Score: 0.326
  6. The IGFBP3/TMEM219 pathway regulates beta cell homeostasis. Nat Commun. 2022 02 03; 13(1):684.
    View in: PubMed
    Score: 0.246
  7. Characterization of Leptin Receptor+ Stromal Cells in Lymph Node. Front Immunol. 2021; 12:730438.
    View in: PubMed
    Score: 0.245
  8. ACTH treatment promotes murine cardiac allograft acceptance. JCI Insight. 2021 07 08; 6(13).
    View in: PubMed
    Score: 0.237
  9. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021 06; 3(6):774-785.
    View in: PubMed
    Score: 0.235
  10. miR-21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy. Am J Transplant. 2021 10; 21(10):3280-3295.
    View in: PubMed
    Score: 0.234
  11. Regulatory B Cells in Autoimmune Diabetes. J Immunol. 2021 03 15; 206(6):1117-1125.
    View in: PubMed
    Score: 0.231
  12. Simultaneous targeting of primary tumor, draining lymph node, and distant metastases through high endothelial venule-targeted delivery. Nano Today. 2021 Feb; 36.
    View in: PubMed
    Score: 0.227
  13. Selective Trafficking of Light Chain-Conjugated Nanoparticles to the Kidney and Renal Cell Carcinoma. Nano Today. 2020 Dec; 35.
    View in: PubMed
    Score: 0.226
  14. Placental proteome abnormalities in women with gestational diabetes and large-for-gestational-age newborns. BMJ Open Diabetes Res Care. 2020 11; 8(2).
    View in: PubMed
    Score: 0.226
  15. Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study. Diabetes Care. 2020 12; 43(12):2999-3006.
    View in: PubMed
    Score: 0.224
  16. Lymph node fibroblastic reticular cells deposit fibrosis-associated collagen following organ transplantation. J Clin Invest. 2020 08 03; 130(8):4182-4194.
    View in: PubMed
    Score: 0.222
  17. Immune heterogeneity of head and tail pancreatic lymph nodes in non-obese diabetic mice. Sci Rep. 2019 07 05; 9(1):9778.
    View in: PubMed
    Score: 0.206
  18. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest. 2018 08 01; 128(8):3490-3503.
    View in: PubMed
    Score: 0.192
  19. Repetitive ischemic injuries to the kidneys result in lymph node fibrosis and impaired healing. JCI Insight. 2018 07 12; 3(13).
    View in: PubMed
    Score: 0.192
  20. Ischemia augments alloimmune injury through IL-6-driven CD4+ alloreactivity. Sci Rep. 2018 02 06; 8(1):2461.
    View in: PubMed
    Score: 0.187
  21. Immunoevasion rather than intrinsic oncogenicity may confer MSCs from non-obese diabetic mice the ability to generate neural tumors. Acta Diabetol. 2017 Jul; 54(7):707-712.
    View in: PubMed
    Score: 0.175
  22. PI3ka and STAT1 Interplay Regulates Human Mesenchymal Stem Cell Immune Polarization. Stem Cells. 2015 Jun; 33(6):1892-901.
    View in: PubMed
    Score: 0.155
  23. Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site. Acta Diabetol. 2015 Oct; 52(5):917-27.
    View in: PubMed
    Score: 0.153
  24. Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens. Diabetes. 2015 Jan; 64(1):158-71.
    View in: PubMed
    Score: 0.147
  25. The rise, fall, and resurgence of immunotherapy in type 1 diabetes. Pharmacol Res. 2015 Aug; 98:31-8.
    View in: PubMed
    Score: 0.146
  26. Novel immunological strategies for islet transplantation. Pharmacol Res. 2015 Aug; 98:69-75.
    View in: PubMed
    Score: 0.146
  27. Harnessing the immunological properties of stem cells as a therapeutic option for diabetic nephropathy. Acta Diabetol. 2014 Dec; 51(6):897-904.
    View in: PubMed
    Score: 0.145
  28. The mechanisms of up-regulation of dendritic cell activity by oxidative stress. J Leukoc Biol. 2014 Aug; 96(2):283-93.
    View in: PubMed
    Score: 0.143
  29. Serine protease inhibitor 6 plays a critical role in protecting murine granzyme B-producing regulatory T cells. J Immunol. 2013 Sep 01; 191(5):2319-27.
    View in: PubMed
    Score: 0.137
  30. Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7. Circulation. 2013 Jan 29; 127(4):463-75.
    View in: PubMed
    Score: 0.131
  31. The novel therapeutic effect of phosphoinositide 3-kinase-? inhibitor AS605240 in autoimmune diabetes. Diabetes. 2012 Jun; 61(6):1509-18.
    View in: PubMed
    Score: 0.124
  32. Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes. Diabetes. 2010 Dec; 59(12):3139-47.
    View in: PubMed
    Score: 0.112
  33. A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice. Diabetes. 2010 Sep; 59(9):2253-64.
    View in: PubMed
    Score: 0.112
  34. The mobilization and effect of endogenous bone marrow progenitor cells in diabetic wound healing. Cell Transplant. 2010; 19(11):1369-81.
    View in: PubMed
    Score: 0.111
  35. Divergent role of donor dendritic cells in rejection versus tolerance of allografts. J Am Soc Nephrol. 2009 Mar; 20(3):535-44.
    View in: PubMed
    Score: 0.099
  36. Targeting CD22 reprograms B-cells and reverses autoimmune diabetes. Diabetes. 2008 Nov; 57(11):3013-24.
    View in: PubMed
    Score: 0.097
  37. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes. 2008 Jul; 57(7):1759-67.
    View in: PubMed
    Score: 0.096
  38. Metabolic and immunological features of the failing islet-transplanted patient. Diabetes Care. 2008 Mar; 31(3):436-8.
    View in: PubMed
    Score: 0.092
  39. Importance of donor- and recipient-derived selectins in cardiac allograft rejection. J Am Soc Nephrol. 2007 Nov; 18(11):2929-36.
    View in: PubMed
    Score: 0.091
  40. Beta 3 integrins regulate lymphocyte migration and cytokine responses in heart transplant rejection. Am J Transplant. 2007 May; 7(5):1080-90.
    View in: PubMed
    Score: 0.088
  41. Kidney-Draining Lymph Node Fibrosis Following Unilateral Ureteral Obstruction. Front Immunol. 2021; 12:768412.
    View in: PubMed
    Score: 0.061
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.